Carbylan Therapeutics, Inc. 4
4 · Carbylan Therapeutics, Inc. · Filed Aug 5, 2015
Insider Transaction Report
Form 4
Clapper David M
Director
Transactions
- Award
Stock Option (Right to Buy)
2015-08-03+29,000→ 29,000 totalExercise: $6.91Exp: 2025-08-03→ Common Stock (29,000 underlying)
Footnotes (1)
- [F1]The option shall vest with respect to 1/36 of the underlying shares upon each monthly anniversary of the vesting commencement date of December 4, 2014.